1 minute read

Healthcare Portfolio Highlights

A Bold Effort To Cure HIV—Using Crispr

Featured in: WIRED

Advertisement

In July, AN HIV-positive man became the first volunteer in a clinical trial aimed at using Crispr gene editing to snip the AIDS-causing virus out of his cells.

In 2019, researchers at Temple University and the University of Nebraska found that using Crispr to delete those regions eliminated HIV from the genomes of rats and mice. A year later, the Temple group also showed that the approach safely removed viral DNA from macaques with SIV, the monkey version of HIV.

COMPANY DESCRIPTION

Excision BioTherapeutics Inc. is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. excision.bio

$2M Ben + GO Philly Fund investment

Founded

Mental Healthtech Company NeuroFlow Raised A $25M Growth Round

Featured in: Technically Philly

Following a $20 million Series B round last year, NeuroFlow just closed a $25 million round of financing to continue its growth, the mental healthtech company announced.

The company makes a platform that facilitates mental healthcare management for patients in between traditional office visits. Last year, NeuroFlow scaled its operations in data analytics, artificial intelligence and direct health record integrations. Its flagship software allows clinicians to see data from wearable devices, assign tasks such as meditation or journaling for patients to complete at home, and send automated motivational emails.

$668K Ben Investment Phila County 2016

Founded

COMPANY DESCRIPTION

NeuroFlow integrates and coordinates evidence-based behavioral health care in traditional medical settings. neuroflow.com

Tech SECTOR OVERVIEW

With its combination of mature B2B and SaaS-based tech companies, its universities creating talent, and a welcoming and supportive startup ecosystem, the Philadelphia tech scene has emerged as a vibrant, continuous source of opportunity.

Ben Franklin’s Tech Investment Group leverages the Philadelphia region’s thriving base of universities, institutions, accelerators, incubators and ecosystem partners to support the growth of emerging tech ventures.

To both founders and funders, the team brings decades of cross-functional experience in entrepreneurship, investment, product development and operations that serve as an “always-on” resource to identify what each company and founder needs most to maximize their return of impact to the region.

This article is from: